Robert Light
Urology · Houston, TXNPI 1518919711
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,088 of the $6,307 with a category attached, or 64.8%. 26 manufacturers reported payments, led by Bayer at 34.2% of the total. Reporting peaked in 2019 at $4,769 and has fallen 91.6% since, to $400 in 2022.
Across 169 payments — averaging $37.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$2K
- Boston Scientific$585
- Johnson & Johnson$585
- Astellas Pharma US Inc$451
- Dendreon Pharmaceuticals LLC$393
- AbbVie$378
- plus $2K from 20 others
What the payments were for
- Consulting fees$1,88030%
- Travel & lodging$1132%
- Food & beverage$4,08865%
- Education$2264%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 11 | $2,159 |
| Boston Scientific | 17 | $585 |
| Johnson & Johnson(2 entities) | 24 | $585 |
| Astellas Pharma US Inc | 21 | $451 |
| Dendreon Pharmaceuticals LLC | 12 | $393 |
| AbbVie(2 entities) | 23 | $378 |
| Pfizer | 10 | $290 |
| Neotract Inc. | 2 | $248 |
| AstraZeneca(2 entities) | 6 | $215 |
| Ferring Pharmaceuticals Inc. | 6 | $178 |
| Tolmar Pharmaceuticals, Inc. | 2 | $118 |
| Merck | 6 | $100 |
| Amgen | 5 | $99 |
| Sun Pharmaceutical Industries Inc. | 2 | $86 |
| Endo Pharmaceuticals Inc. | 5 | $76 |
| Antares Pharma, Inc. | 3 | $54 |
| Myriad Genetic Laboratories, Inc. | 2 | $53 |
| Convatec Inc. | 1 | $40 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $38 |
| Blue Earth Diagnostics | 2 | $30 |
| 180 Medical, Inc. | 1 | $28 |
| Acerus Pharmaceuticals Corporation | 2 | $27 |
| Axonics, Inc. | 1 | $23 |
| Ambu Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $19 |
| Urogen Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,307 in reported general payments places this provider in the 65th percentile of 878 urology providers in Texas.
Other urology in Houston
- Arun RaiHouston$920K
- Donald GriffithHouston$732K
- Jonathan Clavell HernandezHouston$500K
- Ashish KamatHouston$481K
- Mohit KheraHouston$428K
- Ricardo GonzalezHouston$314K
- Richard LinkHouston$261K
- Steven CanfieldHouston$256K
- Run WangHouston$195K
- Kathleen KobashiHouston$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.